These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 4026274)
1. Simultaneous determination of dacarbazine, its photolytic degradation product, 2-azahypoxanthine, and the metabolite 5-aminoimidazole-4-carboxamide in plasma and urine by high-pressure liquid chromatography. Fiore D; Jackson AJ; Didolkar MS; Dandu VR Antimicrob Agents Chemother; 1985 Jun; 27(6):977-9. PubMed ID: 4026274 [TBL] [Abstract][Full Text] [Related]
2. [Determination of dacarbazine in the urine of mice with melanoma by high performance liquid chromatography]. Yue Y; Zhou B; Ai J; Feng S Se Pu; 2020 Nov; 38(11):1302-1307. PubMed ID: 34213101 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules. Breithaupt H; Dammann A; Aigner K Cancer Chemother Pharmacol; 1982; 9(2):103-9. PubMed ID: 7172404 [TBL] [Abstract][Full Text] [Related]
4. Validated hydrophilic interaction LC-MS/MS method for simultaneous quantification of dacarbazine and 5-amino-4-imidazole-carboxamide in human plasma. Liu Y; Zhang W; Yang Y Talanta; 2008 Oct; 77(1):412-21. PubMed ID: 18804654 [TBL] [Abstract][Full Text] [Related]
5. [Polarographic determination of dacarbazine and aminoimidazole carboxamide in human blood and urine]. Wasilewska L; Deres J Acta Pol Pharm; 1981; 38(5):565-71. PubMed ID: 7342697 [No Abstract] [Full Text] [Related]
6. Validated high-performance liquid chromatographic assay for simultaneous determination of dacarbazine and the plasma metabolites 5-(3-hydroxymethyl-3-methyl-1-triazeno)imidazole-4-carboxamide and 5-(3-methyl-1-triazeno)imidazole-4-carboxamide. Safgren SL; Reid JM; Rios R; Ames MM J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):91-6. PubMed ID: 11318431 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanoma. Didolkar MS; Jackson AJ; Lesko LJ; Fitzpatrick JL; Buda BS; Johnston GS; Zech LA J Surg Oncol; 1996 Nov; 63(3):148-58. PubMed ID: 8944058 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of high-dose DTIC. Buesa JM; Urréchaga E Cancer Chemother Pharmacol; 1991; 28(6):475-9. PubMed ID: 1934251 [TBL] [Abstract][Full Text] [Related]
9. Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients. Chabot GG; Flaherty LE; Valdivieso M; Baker LH Cancer Chemother Pharmacol; 1990; 27(2):157-60. PubMed ID: 2249333 [TBL] [Abstract][Full Text] [Related]
11. Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma. Joukhadar C; Klein N; Mader RM; Schrolnberger C; Rizovski B; Heere-Ress E; Pehamberger H; Strauchmann N; Jansen B; Müller M Cancer; 2001 Oct; 92(8):2190-6. PubMed ID: 11596037 [TBL] [Abstract][Full Text] [Related]
12. 5-(3-Hydroxymethyl-3-methyl-1-triazeno imidazole-4-carboxamide is a metabolite of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DIC, DTIC NSC-45388). Kolar GF; Maurer M; Wildschütte M Cancer Lett; 1980 Sep; 10(3):235-41. PubMed ID: 7427920 [TBL] [Abstract][Full Text] [Related]
13. Detection of 5-amino-4-imidazole-N-succinocarboxamide ribotide and hypoxanthine accumulation. A simple method for identification of some purine auxotrophs. Bal J; Pieniazek NJ J Chromatogr; 1979 Feb; 169():474-6. PubMed ID: 395166 [No Abstract] [Full Text] [Related]
14. Analysis and stability study of temozolomide using capillary electrophoresis. Andrasi M; Bustos R; Gaspar A; Gomez FA; Klekner A J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jul; 878(21):1801-8. PubMed ID: 20627825 [TBL] [Abstract][Full Text] [Related]
15. A HPLC method for simultaneous determination of 5-aminoimidazole-4-carboxamide riboside and its active metabolite 5-aminoimidazole-4-carboxamide ribotide in tumor-bearing nude mice plasma and its application to pharmacokinetics study. Cheng X; Guo L; Li Z; Li L; Zhou T; Lu W J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():64-70. PubMed ID: 23340307 [TBL] [Abstract][Full Text] [Related]
16. AICA-riboside: direct quantitation in ultrafiltrates of plasma by HPLC during pharmacokinetic studies in man. Dixon R; Fujitaki J; Chrastil L; Lee J Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):405-8. PubMed ID: 2813961 [TBL] [Abstract][Full Text] [Related]
17. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer. Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179 [TBL] [Abstract][Full Text] [Related]
18. Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide and its metabolites on Novikoff hepatoma cells. Beal DD; Skibba JL; Whitnable KK; Bryan GT Cancer Res; 1976 Aug; 36(8):2827-31. PubMed ID: 179708 [TBL] [Abstract][Full Text] [Related]
19. Determination and validation of a simple high-performance liquid chromatographic method for simultaneous assay of iprodione and vinclozolin in human urine. Carlucci G; Pasquale DD; Ruggieri F; Mazzeo P J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):108-12. PubMed ID: 16203187 [TBL] [Abstract][Full Text] [Related]
20. Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction. Shen F; Decosterd LA; Gander M; Leyvraz S; Biollax J; Lejeune F J Chromatogr B Biomed Appl; 1995 May; 667(2):291-300. PubMed ID: 7663702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]